companydata.dkcompanydata.dk

ACUPHARMA ApS: Financial statements 2021

CVR: 10072956

Source: annual report 2021, Danish Business Authority

01/10/202030/09/2021

ACUPHARMA ApS (CVR 10072956) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK 1,184,849 and a net result of DKK 6,046 compared with DKK -234,576 the year before. That is a decrease of 13.4% compared with the year before. Equity in the 2021 report amounted to DKK 158,276. The solvency ratio was 6.6%. The company had 3 employees in the financial year.

Gross Profit
DKK 1,184,849
Profit/Loss
DKK 6,046
Equity
DKK 158,276
Total Assets
DKK 2,397,293
Employees
3

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2021-1.2 mio.6 t.158 t.3
2020-1.4 mio.-235 t.152 t.3
2019-1.7 mio.33 t.387 t.4
2018-1.7 mio.5 t.154 t.-
2017-1.5 mio.80 t.149 t.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Find more companies like ACUPHARMA ApS

Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.

Try the lead list generator

Events in 2021

ACUPHARMA ApS: The 2020 annual report is outFeb 24, 2021

ACUPHARMA ApS has published its annual report for 2020. Gross profit came to DKK 1,367,554, and the net result was DKK -234,576.

About ACUPHARMA ApS

ACUPHARMA ApS is a Danish company of the type Anpartsselskab based in Roskilde, founded in 2001. The company is registered under the industry Engroshandel med andre fødevarer. The management consists of Christina Uekermann Skive and Jeanne Helsted. The company is owned by SKIVE & HELSTED A/S. The company has 5 employees (2018). In 2025, the company reported a gross profit of DKK 1,150,834 and a net result of DKK 287,572 compared with DKK -258,766 the year before. Equity in the 2025 report amounted to DKK -109,301.

Source: annual report 2025, Danish Business Authority